Insulin-like growth factor-I fails to reverse corticosteroid-induced protein catabolism in growing piglets

Pediatric Research

Volumn 39, Issue 3, 1996, Pages 421-426

  Hellstern, Gerald ^a,b   Reijngoud, Dirk Jan ^a   Stellaard, Frans ^a   Okken, Albert ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CORTICOSTEROID; INSULIN RECEPTOR; SOMATOMEDIN C; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; CORTICOSTEROID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GROWTH HORMONE BLOOD LEVEL; HYPERGLYCEMIA; NEWBORN; NITROGEN BALANCE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SWINE;

EID: 0030025827     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199603000-00008     Document Type: Article

References (33)

1. Loeb JN 1976 Corticosteroids and growth. N Engl J Med 295:547-552
2. Beaufrere B, Horber FF, Schwenk WF, Marsh HM, Matthews D, Gerich JE, Haymond MW 1989 Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol 257:E712-E721
3. Simmons PS, Miles JM, Gerich JE, and Haymond, MW 1984 Increased proteolysis - an effect of increases in plasma cortisol within the physiologic range. J Clin Invest 73:412-420
4. Goudoever JB van, Wattimena DWL, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJJ 1994 Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia (BPD). J Pediatr 124:112-118
5. Williams AF, Jones M 1992 Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia. Arch Dis Child 67:5-9
6. Brownlee KG, Ng PC, Henderson MJ, Smith M, Green JH, Dear PRF 1992 Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child 67:1-4
7. Selye H 1952 Prevention of cortisone overdosage effects with the somatotrophic hormone (STH). Am J Physiol 171:381-384
8. Horber FF, Haymond MW 1990 Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 86:265-272
9. Douglas RG, Gluckman PD, Ball K, Breier B, and Shaw JHF 1991 The effects of infusion of insulin-like growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest 88:614-622
10. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W 1992 Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 75:1186-1191
11. Tavakkol A, Simmen FA, Simmen RC 1988 Porcine insulin-like growth factor-I (pIGF-I): complementary deoxyribonucleic acid cloning and uterine expression of messenger ribonucleic acid encoding evolutionary conserved IGF-I peptides. Mol Endocrinol 2:674-681
12. Schwander JC, Hauri C, Zapf J, Froesch ER 1983 Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113:297-305
13. Guler HP, Zapf J, Froesch ER 1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137-140
14. Somers CJ, Wilson P, Ahern CP, McLoughlin JV 1977 Energy phosphate turnover and glycolysis in skeletal muscle of the Pietrain pig: the effects of premedication with azaperone and pentobarbitone anaesthesia. J Comp Pathol 87:177-183
15. Dundee JW, Haslett WHK 1970 The benzodiazepines: a review of their actions and uses relative to anesthetic practice. Br J Anaesth 42:217-224
16. Goudoever JB van, Sulkers EJ, Chapman TE, Carnielli VP, Efstatopoulos T, Degenhart HJ, Sauer PJJ 1993 Glucose kinetics and glucoregulatory hormone levels in ventilated preterm infants on the first day of life. Pediatr Res 33:583-589
17. Denne SC, Kalhan SC 1986 Glucose carbon recycling and oxidation in human newborns. Am J Physiol 251:E71-E77
18. 13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31:1105-1112
19. Jansen J, Van Buul-Offers SC, Hoogerbrugge CM, Van den Brande JL 1990 Effects of a single cleavage in insulin-like carrier proteins and antibodies. Biochem J 266:513-520
20. Daughaday WH, Mariz IK, Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptors and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51:781-788
21. Kovacs G, Fine RN, Worgall S, Schaefer F, Hunziker EB, Skottner-Lindun A, Mehls O 1991 Growth hormone prevents steroid-induced growth depression in health and uremia. Kidney Int 40:1032-1040
22. Mauras N, Horber FF, Haymond MW 1992 Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J Clin Endocrinol Metab 75:1192-1197
23. D'Ercole AJ, Stiles AD, Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939
24. Miell JP, Taylor AM, Jones J, Buchanan CR, Rennie J, Sherwood R, Leicester R, Ross RJM 1992 Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol 37:542-551
25. Kanis E, Nieuwhof GJ, de Greef KH, van der Hel W, Verstegen MWA, Huisman J, van der Wal P 1990 Effect of recombinant porcine somatotropin on growth and carcass quality in growing pigs: interactions with genotype, gender and slaughter weight. J Anim Sci 68:1193-1200
26. Gluckman PD, Butler JH, Elliott TB 1983 The ontogeny of somatotropic binding sites in ovine hepatic membranes. Endocrinology 112:1607-1612
27. van Toledo-Eppinga L, Kulik W, Houdijk MC, Jakobs C, Delemarre-Vande Waal HA, Lafeber HN 1995 Whole body protein turnover and energy expenditure in intrauterine growth retarded (IUGR) preterm infants during recombinant human growth hormone (rhGH) treatment. Pediatr Res 37:322A(abstr)
28. Miell JP, Taylor AM, Jones J, Holly JMP, Gaillard RC, Pralong FP, Ross RJM, Blum WF 1993 The effects of dexamethasone on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 136:525-533
29. Clemmons DR, Smith-Banks A, Underwood LE 1992 Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 75:234-238
30. Tomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read LC, Ballard FJ 1992 Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone treated rats. Biochem J 282:91-97
31. Yang H, Grahn M, Schalch DS, Ney DM 1994 Anabolic effects of IGF-I coinfused with total parenteral nutrition in dexamethasone-treated rats. Am J Physiol 266:E690-E698
32. Read LC, Tomas FM, Howarth GS, Martin AA, Edson KJ, Gillespie CM, Owens PC, Ballard FJ 1992. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol 133:421-431
33. Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, Shannon RP, Minakeer KL, Miles JM, Rubenstein AH, Vandepol CJ, Guler HP, Good WR, Seaman JJ, Wolfe RR 1993 Effect of recombinant human IGF-I on glucose and leucine kinetics in men. Am J Physiol 265:E8310-E838